Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (<i>Diabetes Metab J</i> 2023;47:394-404)

Lin, Tzu-Yi; Kang, Eugene Yu-Chuan; Shao, Shih-Chieh; Lai, Edward Chia-Cheng; Hwang, Yih-Shiou

Diabetes Metab J. 2023 Jul;47(4):573-574. 10.4093/dmj.2023.0188.

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)

Lin TY^1,2
Kang EYC ^2,3,4
Shao SC^5,6
Lai ECC⁶
Hwang YS^2,3,7

Affiliations

¹Department of Education, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan
²College of Medicine, Chang Gung University, Taoyuan, Taiwan
³Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan
⁴Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan
⁵Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
⁶School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
⁷Department of Ophthalmology, Jen-Ai Hospital Dali Branch, Taichung, Taiwan

KMID: 2544736
DOI: http://doi.org/10.4093/dmj.2023.0188

Reference

1. Lin TY, Kang EY, Shao SC, Lai EC, Garg SJ, Chen KJ, et al. Risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. Diabetes Metab J. 2023; 47:394–404.
Article

2. Chesnaye NC, Stel VS, Tripepi G, Dekker FW, Fu EL, Zoccali C, et al. An introduction to inverse probability of treatment weighting in observational research. Clin Kidney J. 2021; 15:14–20.
Article

3. VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the e-value. Ann Intern Med. 2017; 167:268–74.

4. Centers for Disease Control and Prevention, Department of Health and Human Services. National Diabetes Statistics Report 2020. Atlanta: CDC;2020.

5. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010; 39:481–97.

6. StatPearls. Treasure Island: StatPearls Publishing; 2023. Chapter, Central retinal vein occlusion [cited 2023 Jun 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525985.

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)

Reference

Cited

Save citations to file

Email citations